Pharmacy Times

MARCH 29, 2025

PD-L1 immune checkpoint inhibitors are now standard for early-stage non-metastatic non-small cell lung cancer (NSCLC), with neoadjuvant, adjuvant, and perioperative strategies improving survival and outcomes.

Immunization 65

Immunization 65

Pharmacy Times

FEBRUARY 21, 2025

The AACR Immunotherapy Conference 2025 will provide pharmacists with the opportunity to engage with cutting-edge cancer immunotherapy research, explore advancements in treatments, such as immune checkpoint inhibitors and CAR T-cell therapy, and connect with key leaders in the field.

Immunization 82

Immunization 82

Fierce Pharma

JUNE 29, 2023

. | By 2030, Sanofi figures its immunizations could generate more than €10 billion in annual sales, the company said during a vaccines R&D event Thursday.

Vaccines 77

Vaccines Immunization 77

pharmaphorum

JUNE 15, 2022

Cytokines have long been investigated for their potential as cancer treatments – selectively stimulate tumour-fighting immune cells – with varying levels of success. Trutino’s lead in-house asset is in early-stage development and scheduled to start clinical testing in solid tumours in 2025.

Immunization 98

Immunization Vaccines 98

STAT

JUNE 10, 2024

… Moderna announced that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines targeting those viruses , STAT says. A combo shot could improve uptake of both flu and Covid vaccines.

Vaccines 102

Vaccines Immunization 102

NF2 BioSolutions

OCTOBER 4, 2024

Over the last three years, we have been investigating how the body’s immune cells (which are usually the body’s natural defence system against infection) can actually play a role in driving tumour growth. Sporadic and NF2 VS are highly similar, specific macrophages found in growing VS, meningioma and VS have different immune profiles.

Immunization 105

Immunization Communication 105

STAT

APRIL 11, 2024

billion in 2025 for the entire Medicare program, a spokesperson for the Centers for Medicare and Medicaid Services confirmed. These include oxytocin, which is used during childbirth; Rho(D) immune globulin, which helps some women during pregnancy; standard-of-care chemotherapy, pain and sedation medicines; and ADHD pills.

Chemotherapy 97

Chemotherapy Immunization 97

Pharma Tutor

JANUARY 27, 2025

Understanding the Impact of Guillain-Barr syndrome Pradip Mahajan Mon, 01/27/2025 - 15:41 Guillain-Barre syndrome (GBS) is an autoimmune disease. It's a rare neurological disorder that occurs when the body's immune system attacks its own peripheral nerves that carry signals from the brain and spinal cord to the rest of the body.

Immunization 52

Immunization 52

Outsourcing Pharma

JUNE 20, 2023

A small molecule compound has shown to induce strong anti-tumor immune responses â an area where medical need is high.

Compounding 52

Compounding Immunization 52

Pharmaceutical Technology

MAY 19, 2023

The US Food and Drug Administration (FDA) has approved AbbVie’s Rinvoq (upadacitinib) for patients with Crohn’s disease who do not respond to TNF blockers, a common immune suppressant treatment for the condition.

Mayo Clinic 105

Mayo Clinic Dosage FDA Immunization 105

The Checkup by Singlecare

NOVEMBER 6, 2023

According to the FDA announcement, the most serious side effect of Wezlana is infection because the prescription affects your immune response. Reuters reported that the settlement terms were confidential but would allow Amgen to begin selling its biosimilar of Stelara no later than January 1, 2025. How much will Wezlana cost?

FDA 110

FDA Immunization 110

pharmaphorum

DECEMBER 21, 2020

Boston, US-based Alexion spent a lot of 2019 arguing the merits of remaining independent, saying that while Soliris is approaching the end of its patent life – with heavyweight competitors like Amgen already eyeing the biosimilar market for the drug – Ultomiris and its pipeline could help drives sales to $9 to $10 billion in 2025.

Chemotherapy 126

Chemotherapy Immunization FDA 126

PQA

MARCH 28, 2025

We also highlight our members' perspectives on pharmacy interoperability, immunizations and nutrition. Authors of the report believe removing these protocols and giving more authority to pharmacists would significantly improve immunization rates among U.S. Learn morebelow. Of note, PQA is conducting an immunizationpilot.

Health and Personal Care Stores 52

Health and Personal Care Stores Immunization Vaccines 52

PQA

OCTOBER 4, 2024

As part of this work, PQA has launched a proof-of-concept pilot using several PQA pharmacy measure concepts to evaluate the effectiveness of pharmacies in improving adult immunization rates through value-based arrangements (VBA) with payers. Submissions for poster abstract proposals are due Friday, January 10, 2025. Learn more.

Immunization 52

Immunization Specialty Pharmacies 52

The Thyroid Pharmacist

NOVEMBER 29, 2023

This product is designed to support the rapid reproduction of beneficial bacteria throughout the small and large intestines, to promote healthy gastrointestinal and immune function. Research has shown that the cat’s claw plant may have antiviral, anti-inflammatory, antioxidant, and immune-modulating properties.

Health and Personal Care Stores 73

Health and Personal Care Stores Immunization Labelling Compounding 73

pharmaphorum

JANUARY 10, 2022

Fellow big pharma company, Sanofi has also made a number of moves to bolster its R&D pipeline for mRNA vaccines – not least when it stated that it would invest €400 million each year into the development of mRNA vaccines, with the aim of developing six clinical candidates by the end of 2025.

Vaccines 111

Vaccines Immunization FDA 111

Pharmaceutical Technology

DECEMBER 6, 2022

Until 2025, the companies will equally share the research and intellectual property licensing expenses under the partnership. Individuals with weak immune systems could have severe symptoms, and congenitally infected babies could suffer from an intellectual disability and vision and hearing loss.

Vaccines 52

Vaccines Immunization 52

European Pharmaceutical Review

SEPTEMBER 5, 2024

2 These are cells commonly found in the stroma of the tumour, which play an important role in inhibiting the body’s own immune response to the tumour, mediated through CD8+ T-cells (tumour-infiltrating lymphocytes). Research in the last few years has shown NOX4 in tumour cells is linked to the growth of cancer-associated fibroblasts (CAFs).

Immunization 59

Immunization 59

pharmaphorum

AUGUST 22, 2021

Prior to CheckMate-274, no immune checkpoint inhibitor had shown efficacy as adjuvant therapy for these patients, and BMS could have some time on its own in the category. Cisplatin is sometimes used to reduce the tumour before surgery or as adjuvant treatment afterwards, but there isn’t much data to support its benefit in invasive UC.

FDA 78

FDA Chemotherapy Immunization 78

pharmaphorum

SEPTEMBER 15, 2020

The UK has also taken an option on another 40 million doses in 2022, and between 30 and 90 million until 2025. The hope is that directly targeting the cells lining the airways may stimulate a more effective immune response against SARS-CoV-2. If exercised, that second phase would be worth €900 million to the French biotech.

Vaccines 80

Vaccines Immunization 80

The Checkup by Singlecare

NOVEMBER 3, 2023

Type 1 diabetes occurs when your immune system prevents your pancreas from producing enough insulin. The 2020–2025 Dietary Guidelines for Americans recommend that Americans limit the amount of sugar they consume to less than 10% of their daily intake of calories. Does sugar cause diabetes?

Labelling 116

Labelling Packaging Immunization 116

PQA

NOVEMBER 14, 2024

Cost highlighted progress towards completion of PQA’s strategic plan, Blueprint PQA 2025. By participating in PQA pilots, some organizations have been able to identify successful pharmacy interventions and make plans for 2025 and beyond. Save the date to join us at the 2025 PQA Annual Meeting, May 19-21 in Tampa! Sign

Specialty Pharmacies 52

Specialty Pharmacies Documentation Patient Care Immunization 52

Pharmaceutical Technology

JUNE 20, 2023

The project is supported by A$400m in funding from the Victorian government and A$250m from three founding partners, namely the Burnet Institute, the Peter Doherty Institute for Infection and Immunity, and the University of Melbourne.

Immunization 52

Immunization Vaccines 52

Pharmaceutical Technology

MAY 25, 2023

Apexigen discovers and develops a new generation of antibody therapeutics to treat cancer, along with new immuno-oncology products to harness the immune system to combat and eradicate cancer. Pyxis Oncology will issue 0.1725 shares of its common stock, with par value of $0.001 per share, for each Apexigen share.

Immunization 52

Immunization 52

The Thyroid Pharmacist

MARCH 7, 2025

1] This inability to detox properly can trigger or worsen autoimmune symptoms, as these chemical exposures can trigger immune dysregulation. [2] Reduced inflammation and joint pain Toxins can trigger the immune system, leading to chronic inflammation, joint pain, and autoimmune flares. Accessed February 20, 2025. 3] Faber S.

Health and Personal Care Stores 60

Health and Personal Care Stores Labelling Immunization Packaging 60

pharmaphorum

OCTOBER 12, 2022

Similar to how we injected mRNA into people to trigger an immune response and train their immune system against COVID-19, genomic medicine repairs cellular or molecular mechanisms that are dysfunctional and cause disease.”. By 2025, pharma’s investment in AI is expected to reach $3 billion.

Immunization 105

Immunization Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

PQA

DECEMBER 13, 2024

are wrapping up year four of Blueprint PQA 2025, PQAs five-year strategic plan. This two-year project will begin in early 2025. That work will continue in 2025. This fall, we launched a pilot to evaluate the effectiveness of pharmacies in improving adult immunization rates through VBAs with payers.

Communication 52

Communication Patient Care Immunization 52

pharmaphorum

JULY 28, 2021

Under the agreement, Calico is responsible for research and early development until 2025 and will take projects through phase 2a trials until 2030, with AbbVie having an option to take over projects once they reach later-stage development and lead commercialisation efforts.

Immunization 59

Immunization 59

European Pharmaceutical Review

MARCH 14, 2024

This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function. Topline data from Vera’s ORIGIN Phase III trial of atacicept is expected in the first half of 2025. IgAN is the most common primary glomerulonephritis worldwide.

Labelling 98

Labelling Immunization FDA 98

European Pharmaceutical Review

MARCH 14, 2024

This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function. Topline data from Vera’s ORIGIN Phase III trial of atacicept is expected in the first half of 2025. IgAN is the most common primary glomerulonephritis worldwide.

Labelling 98

Labelling Immunization FDA 98

PQA

NOVEMBER 1, 2024

Reviewing Vaccination Recommendations Stanford Health Care's David Ha presented at this year’s NCPA Annual Meeting and Exposition a comprehensive overview of vaccines for four common respiratory viruses and touched on the latest updates from the October 2024 CDC Advisory Committee on Immunization Practices meeting. Learn more.

Specialty Pharmacies 52

Specialty Pharmacies Vaccines Chemotherapy Immunization 52

DiversifyRx

DECEMBER 11, 2024

What’s the secret sauce to growing your pharmacy in 2025? Identify Key Areas of Focus: Think about the services or products you want to promote, such as weight loss programs, immunizations, or non-PBM revenue streams. May: Immunization Awareness Boost summer travel vaccine promotions. Plan weekly content for each theme.

Vaccines 52

Vaccines Immunization Independent Pharmacies 52

PQA

SEPTEMBER 25, 2023

We continue to play a central role in driving meaningful improvements and positive changes related to medication safety, adherence and appropriate use.The 2023 PQA Annual Report documents our progress towards Blueprint PQA 2025. There are still numerous opportunities to be involved with PQA and impact quality medication use in 2023.

Specialty Pharmacies 52

Specialty Pharmacies Documentation Patient Care Immunization 52

The Checkup by Singlecare

JANUARY 31, 2024

It may help protect against heart disease, improve immunity, and more. According to the Dietary Guidelines for Americans 2020–2025 , a healthy eating plan emphasizes fruit, vegetables, whole grains, lean protein, and low-fat dairy. They are also a source of folate, B vitamins, vitamin K, calcium, magnesium, and potassium.

Mayo Clinic 105

Mayo Clinic Compounding Immunization 105

DiversifyRx

DECEMBER 4, 2024

Let’s break down the exact steps you can take to ensure your year ends on a high note and your pharmacy is ready to thrive in 2025. Optimize Your Tax Situation: Talk to your accountant about potential end-of-year tax strategies, like prepaying expenses for 2025 or making investments in new equipment that can be depreciated.

Inventory Audits 52

Inventory Audits Independent Pharmacies Customer Service Compounding 52

The Checkup by Singlecare

SEPTEMBER 10, 2024

There have been several biosimilars approved, including Wezlana , Selarsdi, and Pyzchiva, but they are not expected to be available until early 2025. But Stelara is a biologic product , meaning it will have what’s called a biosimilar instead of a generic version. Continue reading to learn more about Stelara and its biosimilars.

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

European Pharmaceutical Review

DECEMBER 19, 2023

Available from: [link] Vaccines and Immunization. Immunization coverage. Since vaccines can now be reformulated to meet the relevant WHO guidelines, the route to a future of fridge-free vaccines is open. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat Biotechnol. Injection Safety Fact Sheet. Internet] WHO.

Vaccines 111

Vaccines Communication Immunization Documentation 111